Evotec (OTCMKTS:EVTCY) Sets New 12-Month Low at $4.89

Shares of Evotec SE (OTCMKTS:EVTCY) reached a new 52-week low on Tuesday . The company traded as low as $4.89 and last traded at $4.95, with a volume of 31345 shares changing hands. The stock had previously closed at $4.86.

Evotec Stock Up 1.9 %

The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53. The firm has a market cap of $1.63 billion, a PE ratio of 11.85 and a beta of 0.98. The stock has a fifty day simple moving average of $4.97 and a two-hundred day simple moving average of $7.11.

Evotec Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.